Guided Therapeutics Inc financial data

Symbol
GTHP on OTC
Location
5835 Peachtree Corners East, Suite B, Peachtree Corners, GA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 14.5 % -32.2%
Quick Ratio 9.81 % -15.1%
Debt-to-equity -120 % +9.53%
Return On Equity 49.4 %
Return On Assets -249 % -102%
Operating Margin -1.23K % +77.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83.6M shares +37%
Common Stock, Shares, Outstanding 83.6K shares
Entity Public Float 3.72M USD -67.6%
Common Stock, Value, Issued 3.47M USD +0.67%
Weighted Average Number of Shares Outstanding, Basic 57K shares +10.8%
Weighted Average Number of Shares Outstanding, Diluted 68.3K shares +24.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 178K USD +368%
Research and Development Expense 482K USD +1.9%
Selling and Marketing Expense 215K USD -24%
General and Administrative Expense 1.61M USD +21.5%
Operating Income (Loss) -2.2M USD -6.5%
Nonoperating Income (Expense) -273K USD -435%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.63M USD -22.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.61M USD -49%
Earnings Per Share, Basic 0 USD/shares -25%
Earnings Per Share, Diluted 0 USD/shares -25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 731K USD -72.9%
Accounts Receivable, after Allowance for Credit Loss, Current 6K USD +200%
Inventory, Net 583K USD -8.33%
Other Assets, Current 123K USD -41.7%
Assets, Current 799K USD -23.4%
Property, Plant and Equipment, Net 18K USD -28%
Operating Lease, Right-of-Use Asset 69K USD -57.9%
Other Assets, Noncurrent 17K USD 0%
Assets 903K USD -27.7%
Accounts Payable, Current 2.38M USD +13.4%
Accrued Liabilities, Current 952K USD +3.14%
Liabilities, Current 6.47M USD +7.39%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 6.55M USD +6.19%
Retained Earnings (Accumulated Deficit) -156M USD -1.83%
Stockholders' Equity Attributable to Parent -5.65M USD -14.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -5.7M USD
Liabilities and Equity 903K USD -27.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -331K USD -231%
Net Cash Provided by (Used in) Financing Activities 58K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 83.6K shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -273K USD -87%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 87K USD -55.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 20K USD +66.7%
Deferred Tax Assets, Valuation Allowance 17.6M USD -2.19%
Deferred Tax Assets, Gross 17.6M USD -2.19%
Operating Lease, Liability 76K USD -57.3%
Depreciation 2K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 80K USD -59.4%
Property, Plant and Equipment, Gross 1.62M USD +0.12%
Operating Lease, Liability, Current 76K USD -25.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 50K USD +78.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 50K USD -57.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4K USD -78.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 50K USD -56.5%
Deferred Tax Assets, Operating Loss Carryforwards 16M USD -2.63%
Lessee, Operating Lease, Liability, to be Paid, Year Four 118K USD 0%
Additional Paid in Capital 145M USD +2.44%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 14.8K USD -86.1%
Interest Expense 567K USD +77.7%